Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance
Liam Baird, Masayuki Yamamoto
Redox Biology (2023) Vol. 67, pp. 102904-102904
Open Access | Times Cited: 11

Showing 11 citing articles:

Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function
Jun Takahashi, Takafumi Suzuki, Miu Sato, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114104-114104
Open Access | Times Cited: 7
NRF2 signaling pathway in chemo/radio/immuno-therapy resistance of lung cancer: Looking beyond the tip of the iceberg
Sri Vidya Ramisetti, Tapas Patra, Vinayak Munirathnam, et al.
Archivos de Bronconeumología (2024) Vol. 60, pp. S59-S66
Closed Access | Times Cited: 5
NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma
Samera H. Hamad, Rani S. Sellers, Nathan Wamsley, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 2, pp. 487-495
Open Access | Times Cited: 4
The Dynamic Role of Ferroptosis in Cancer Immunoediting: Implications for Immunotherapy
Jun Lan, Dan Cai, Shuang Gou, et al.
Pharmacological Research (2025) Vol. 214, pp. 107674-107674
Open Access
The clinical-grade CBP/ p300 inhibitor CCS1477 represses the global NRF2-dependent cytoprotective transcription program and re-sensitizes cancer cells to chemotherapeutic drugs
Ke Wang, Liam Baird, Masayuki Yamamoto
Free Radical Biology and Medicine (2025)
Closed Access
The role of Keap1-Nrf2 signaling pathway in the treatment of respiratory diseases and the research progress on targeted drugs
Mengyang Zhang, Jing Wang, Runze Liu, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37326-e37326
Open Access | Times Cited: 3
Monotropein alleviates septic acute liver injury by restricting oxidative stress, inflammation, and apoptosis via the AKT (Ser473)/GSK3β (Ser9)/Fyn/NRF2 pathway
Kunmei Xie, F. Wang, Yue Yang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113178-113178
Closed Access | Times Cited: 2
The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a Preclinical Mouse Model of Established Lung Cancer
Jessica A. Moerland, Karen T. Liby
Antioxidants (2024) Vol. 13, Iss. 6, pp. 621-621
Open Access | Times Cited: 1
Research progress on oncoprotein hepatitis B X‑interacting protein (Review)
Lei Cheng, Lijuan Guo, Teng Zou, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 6
Open Access
New uses of halofuginone to treat cancer
Runan Zuo, Xinyi Guo, Xinhao Song, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 15, Iss. 3, pp. 101080-101080
Open Access
Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma
Hiroyuki Oshikiri, Keiko Taguchi, Wataru Hirose, et al.
Molecular and Cellular Biology (2024), pp. 1-19
Open Access
Page 1

Scroll to top